13F HOLDINGS REPORT
Pivotal bioVenture Partners Investment Advisor LLC
Quarter ended Q1 2024 · Filed May 14, 2024 · Accession 0001012975-24-000204
Total Value
$155.6M
Positions
11
Other Managers
1
Confidential Omitted
No
Holdings (11)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | VAXCYTE INC | PCVX | 793,036 | $54.2M | 34.82% |
| 2 | INOZYME PHARMA INC | 45790W108 | 4,494,851 | $34.4M | 22.13% |
| 3 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 2,028,008 | $20.1M | 12.92% |
| 4 | OCULIS HOLDING AG | OCSAW | 1,595,918 | $19.2M | 12.36% |
| 5 | FUSION PHARMACEUTICALS INC | 36118A100 | 563,385 | $12.0M | 7.72% |
| 6 | RALLYBIO CORP | RLYB | 2,404,644 | $4.4M | 2.86% |
| 7 | EXSCIENTIA PLC | 30223G102 | 770,500 | $4.4M | 2.83% |
| 8 | BOLT BIOTHERAPEUTICS INC | BOLT | 1,891,467 | $2.6M | 1.70% |
| 9 | VIGIL NEUROSCIENCE INC | 92673K108 | 560,595 | $1.9M | 1.23% |
| 10 | IO BIOTECH INC | IOBT | 864,197 | $1.5M | 0.96% |
| 11 | ALIGOS THERAPEUTICS INC | ALGS | 743,215 | $728,351 | 0.47% |